<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.44071.040</object-id><label>Table 2.</label><caption><title>HPLC purification conditions for the peptides used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Peptide</th><th>HPLC column</th><th>Flow rate</th><th>Gradient</th></tr></thead><tbody><tr><td>F</td><td>Phenomenex C4 Luna&#160;(100 &#197;, 10 &#956;m, 10 &#215; 250 mm)</td><td>5 mL/min</td><td>20 to 80% Buffer B</td></tr><tr><td>F12</td><td>Phenomenex C12 Jupiter (90 &#197;, 10 &#956;m, 21.2 &#215; 250 mm)</td><td>5 mL/min</td><td>25 to 45% Buffer B</td></tr><tr><td>F30</td><td>Phenomenex C12 Jupiter (90 &#197;, 10 &#956;m, 21.2 &#215; 250 mm)</td><td>10 mL/min</td><td>20 to 45% Buffer B</td></tr><tr><td>cF30 (pre-cyclization)</td><td>Phenomenex C12 Jupiter (90 &#197;, 10 &#956;m, 21.2 &#215; 250 mm)</td><td>10 mL/min</td><td>20 to 45% Buffer B</td></tr><tr><td>cF30</td><td>Phenomenex C4 Jupiter (100 &#197;, 10 &#956;m, 10 &#215; 250 mm)</td><td>5 mL/min</td><td>10 to 35% Buffer B</td></tr><tr><td>FF30</td><td>Phenomenex C12 Jupiter (90 &#197;, 10 &#956;m, 21.2 &#215; 250 mm)</td><td>10 mL/min</td><td>29 to 37% Buffer B</td></tr><tr><td>cFF30 (pre-cyclization</td><td>Phenomenex C12 Jupiter (90 &#197;, 10 &#956;m, 21.2 &#215; 250 mm)</td><td>10 mL/min</td><td>20 to 45% Buffer B</td></tr><tr><td>cFF30</td><td>Phenomenex C4 Jupiter (100 &#197;, 10 &#956;m, 10 &#215; 250 mm)</td><td>5 mL/min</td><td>27 to 38% Buffer B</td></tr></tbody></table></table-wrap>